A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Non-fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00864019
- Locations
- 🇺🇸
CEDRA Clinical Research, LLC, Austin, Texas, United States
The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2019-07-09
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT00864240
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Abrika Bupropion 150 mg XL Tablet, single dose
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2010-08-23
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT00863941
- Locations
- 🇺🇸
SFBC Ft. Myers, Inc., Ft. Myers, Florida, United States
A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: COMBONOX® tablets, single dose
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00864526
- Locations
- 🇺🇸
Gateway Medical Research, Inc, St. Charles, Missouri, United States
A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00864058
- Locations
- 🇺🇸
Gateway Medical Research, Inc, St. Charles, Missouri, United States
A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Non-fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT00864305
- Locations
- 🇺🇸
Gateway Medical Research, Inc, St. Charles, Missouri, United States
A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Ramipril10 mg Capsules, single doseDrug: Atlace® 10 mg capsules, single dose
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00864448
- Locations
- 🇺🇸
CEDRA Clinical Research, LLC, Austin, Texas, United States
A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Grifulvin V® 125 mg/5 mL Suspension, single dose
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00863863
- Locations
- 🇨🇦
Biovail Contract Research (A Division of Biovail Corporation), Toronto, Ontario, Canada
A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT00864565
- Locations
- 🇨🇦
Anapharm Inc, Quebec, Canada
A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT00864435
- Locations
- 🇨🇦
Biovail Contract Research (A Division of Biovail Corporation), Toronto, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath